Interpreting results from trials of pneumococcal conjugate vaccines: A statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes

American Journal of Epidemiology

Volumn 154, Issue 1, 2001, Pages 85-92

  Lipsitch, Marc ^a,b,c  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bacterial vaccines; Carrier state; Models, statistical; Streptococcus pneumoniae; Vaccination; Vaccines, conjugate

Indexed keywords

BACTERIAL VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIUM CARRIER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; SEROTYPE; STATISTICAL MODEL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BAYES THEOREM; CARRIER STATE; CLINICAL TRIALS; HUMANS; MODELS, STATISTICAL; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0035400166     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/154.1.85     Document Type: Article

References (28)

1. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2. Some aspects of the pneumococcal carrier state
3. 197 (PncCRM9) on nasopharyngeal (NP) carriage of vaccine type and non-vaccine type S. pneumoniae (Pnc) strains among day-care-center (DCC) attendees
4. Immunogenicity and impact on nasopharyngeal carriage of a nonvalent pneumococcal conjugate vaccine
5. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
6. Carriage of pneumococci after pneumococcal vaccination
7. Effect of vaccination with octavalent protein conjugated vaccines on pneumococcal carriage in infants
8. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of the Northern California Kaiser Permanente Efficacy Trial
9. Conjugate vaccines and the carriage of Haemophilus influenzae type b
10. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine
11. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model
12. Vaccination against colonizing bacteria with multiple serotypes
13. The role of bacterial antagonism in pneumococcal colonization of the human pharynx
14. Bacterial interference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci
15. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I
16. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II
17. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae
18. Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae
19. Epidemic pneumococcal pneumonia. III. Carrier studies
20. Multiple colonization of the upper respiratory tract of Papua New Guinea children with Haemophilus influenzae and Streptococcus pneumoniae
21. Posterior predictive assessment of model fitness via realized discrepancies
22. Comment
23. Asymptotic distribution of p-values in composite null models
24. A language and program for complex Bayesian modeling
25. Effect of a 7-valent pneumococcal conjugate vaccine on nasopharyngeal (NP) carriage among Navajo and White Mountain Apache (N/WMA) infants
26. Efficacy of a pneumococcal conjugate vaccine against acute otitis media